Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
N/A
-5,766 Reduced 1.16%
491,013 $0
Q1 2024

May 15, 2024

SELL
N/A
-425 Reduced 0.09%
496,779 $0
Q4 2023

Feb 14, 2024

SELL
N/A
-4,130 Reduced 0.82%
497,204 $0
Q3 2023

Nov 13, 2023

BUY
N/A
2,025 Added 0.41%
501,334 $0
Q2 2023

Aug 11, 2023

SELL
N/A
-960 Reduced 0.19%
499,309 $0
Q1 2023

May 15, 2023

SELL
N/A
-1,450 Reduced 0.29%
500,269 $0
Q4 2022

Feb 13, 2023

SELL
$0.0 - $9.95 $0 - $226,561
-22,770 Reduced 4.34%
501,719 $3.25 Million
Q3 2022

Nov 14, 2022

BUY
$8.57 - $11.57 $55,087 - $74,371
6,428 Added 1.24%
524,489 $4.66 Million
Q2 2022

Aug 12, 2022

SELL
$8.84 - $11.64 $4,199 - $5,529
-475 Reduced 0.09%
518,061 $5.17 Million
Q1 2022

May 12, 2022

BUY
$10.07 - $11.93 $200,050 - $237,001
19,866 Added 3.98%
518,536 $6.01 Million
Q4 2021

Feb 14, 2022

SELL
$7.95 - $11.24 $70,794 - $100,092
-8,905 Reduced 1.75%
498,670 $5.54 Million
Q3 2021

Nov 12, 2021

BUY
$9.22 - $12.44 $121,243 - $163,586
13,150 Added 2.66%
507,575 $4.68 Million
Q2 2021

Aug 13, 2021

BUY
$9.91 - $12.78 $173,920 - $224,289
17,550 Added 3.68%
494,425 $5.56 Million
Q1 2021

May 18, 2021

BUY
$10.44 - $12.22 $358,875 - $420,062
34,375 Added 7.77%
476,875 $5.06 Million
Q4 2020

Feb 16, 2021

BUY
$9.3 - $11.77 $373,608 - $472,836
40,173 Added 9.99%
442,500 $4.8 Million
Q3 2020

Nov 16, 2020

BUY
$7.59 - $10.8 $295,782 - $420,876
38,970 Added 10.72%
402,327 $3.91 Million
Q2 2020

Aug 14, 2020

BUY
$7.96 - $11.54 $37,810 - $54,814
4,750 Added 1.32%
363,357 $2.89 Million
Q1 2020

May 15, 2020

BUY
$7.69 - $11.68 $3,460 - $5,256
450 Added 0.13%
358,607 $3.12 Million
Q4 2019

Feb 14, 2020

BUY
$9.09 - $11.89 $3.26 Million - $4.26 Million
358,157 New
358,157 $4.05 Million

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Visionary Wealth Advisors Portfolio

Follow Visionary Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Visionary Wealth Advisors with notifications on news.